All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Using AI-Powered Sentiment Analysis to Strengthen Marketing and Differentiation in Homeopathic Products
By Brenda van Goethem, Director of Regulatory Compliance and Change Management at Nature's Way Brands, LLC (Schwabe North America) and AAHP Board of Director Artificial...
Marketing of Homeopathic Drug Products: OTC vs. Rx-only
By Eric L. Foxman, Pharm. (Ret.) On a single day in mid-November, FDA issued five warning letters* to a like number of distributors / manufacturers of homeopathic drug...
Honor The Basics
By Mark Land, M.S., RAC-US, AAHP President In this issue, we examine marketing of homeopathic drug products. As I read through the articles, what consistently came to mind was that the...
Measles and OTC Homeopathic Treatment: AAHP’s Position
As reported outbreaks of measles have risen in the U.S. recently, AAHP reminds manufacturers and marketers that Federal law prohibits the sale of products-homeopathic or...
AAHP 2026 Outlook
By Mark Land, M.S., RAC-US, AAHP President Building on lessons learned in previous years and focusing our attention on the issues of our industry and...
Supporting Volunteers, Securing the Future: The Role of Professional Management at AAHP
By Emily Leonczyk, MBA, CAE, President & CEO of The Markens Group For me, the start of a new year invites a welcome pause, reflections over...
2025 Year in Review
By Mark Land, M.S., RAC-US, AAHP This year was dominated by change-political change, retail change, and change at AAHP. The association's newsletter and special e-blasts continue to brief the homeopathic...
